You are here:
Publication details
THREE-PART PRICING TO REWARD PHARMACEUTICAL INNOVATION AND INCREASE ACCESS: CASE OF PCSK9 INHIBITORS
| Authors | |
|---|---|
| Year of publication | 2018 |
| Type | Conference abstract |
| Citation |
| Authors | |
|---|---|
| Year of publication | 2018 |
| Type | Conference abstract |
| Citation |